Jean Jacques Mention

Corporate Officer/Principal presso OSE IMMUNOTHERAPEUTICS

Health Technology

Profilo

Jean Jacques Mention is currently the Chief Business Officer at OSE Immunotherapeutics SA. Prior to this, he held positions as Director of Business Development at Axenis SAS and Head of Business Development at genOway SA.

Posizioni attive di Jean Jacques Mention

Società	Posizione	Inizio
OSE IMMUNOTHERAPEUTICS	Corporate Officer/Principal	-

Tutte le posizioni attive di Jean Jacques Mention

Precedenti posizioni note di Jean Jacques Mention

Società	Posizione	Fine
GENOWAY	Corporate Officer/Principal	-
Axenis SAS Axenis SAS BiotechnologyHealth Technology Part of genOway SA, Axenis SAS develops gene technology and products. The private company is based in Paris, France. Axenis was acquired by genOway SA on September 04, 2018 for $0.23 million.	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Jean Jacques Mention

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Jean Jacques Mention

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
GENOWAY	Health Technology
OSE IMMUNOTHERAPEUTICS	Health Technology

Aziende private	1
Axenis SAS Axenis SAS BiotechnologyHealth Technology Part of genOway SA, Axenis SAS develops gene technology and products. The private company is based in Paris, France. Axenis was acquired by genOway SA on September 04, 2018 for $0.23 million.	Health Technology

Vedi le connessioni aziendali